Download presentation
1
Macrophage Biology Lab, San Francisco
RNAi II (Continued) Macrophage Biology Lab, San Francisco Tamara Roach Bob Rebres Bill Seaman
2
Thanks Melissa Kachura David Quan Carrie Wong
3
Use of RNAi to target signaling molecules
C5a UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Gb 1, 2, 4, 5 + Gg PI 3-kinases PLCs Ca2+ PIP3 P - Akt
4
Summary of shRNA-transduced RAW264.7 lines
37 Lines have been studied, covering 31 targets (4 new/week) Using prescreened shRNA plasmids, target knock-down was >75% in almost all transduced lines (protein or mRNA) >90% in two-thirds >99% in one-third Apart from receptor knock-downs, alterations in signaling were observed in: Half of responses to IgG2a One-third of responses to C5a Only one response to UDP by 1.5-fold cutoff, but more by stats Expected phenotypes were usually detected Unexpected phenotypes were frequent
5
Gaq facilitates signaling through P2Y receptors
C5a UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Gb 1, 2, 4, 5 + Gg PI 3-kinases PLCs Ca2+ PIP3
6
shRNA against Gaq reduced the peak [Ca2+]i response to UDP but increased the response to IgG2a
Expression of Gq Responses to FXM Ligands (Western blot) (Peak [Ca2+]i) IB: Gq 75 50 37 Gq Vector Grk2 Mol.Biol.Lab.
7
shRNA against Gaq reduced the peak [Ca2+]i response to UDP
8
Gb2 is utilized by C5aR C5a UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg
Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Gb 1, 2, 4, 5 + Gg Gai (and Gao) families use Gb2 to activate PLC Gaq activates PLC directly PI 3-kinases PLCs Ca2+ PIP3
9
shRNA against G2 inhibited the response to both C5a and IgG2a
G2 expression Responses to FXM Ligands (Western blot) (Peak [Ca2+]i) IB: G2 49 38 28 Vector G 2 PTEN Mol.Biol.Lab
10
The C5a signaling defect was observed in each of 3 G2-shRNA lines
11
The IgG2a signaling defect was observed in 2 of 3 G2-shRNA lines
12
The C5a receptor signals through Gai proteins
UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Gb 1, 2, 4, 5 + Gg PI 3-kinases PLCs Ca2+ PIP3
13
shRNA against Gi2 enhanced the response to C5a
Gi2 Expression Responses to FXM Ligands (Western blot) (Peak [Ca2+]i) IB: Gi2 Vector PTEN Gi2A Gi3 Mol.Biol.Lab
14
The enhanced [Ca2+]i response to C5a was observed in each of 2 Gi2-targeted lines
Gai2 100nM C5a Vector (HBSS) 100 (nM) Line #2 ] i 2+ 50 [Ca 50 100 150 Time
15
Pertussis toxin inhibits both Gai2 and Gai3
C5a UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Pertussis toxin Gb 1, 2, 4, 5 + Gg PLCs PI 3-kinases Ca2+ PIP3
16
The [Ca2+]i response in Gi2-targeted cells was partially resistant to pertussis toxin
100 nM C5a
17
High concentrations of pertussis toxin failed to eliminate the [Ca2+]i response to C5a in Gi2-targeted cells (ng/ml)
18
The next step: targeting both Gai2 and Gai3
C5a UDP IgG2a P2Y6 P2Y2 FcgRI C5aR Fcg Gai2 / Gai3 Gaq /Ga11 ITAM ITAM PTKs Gb 1, 2, 4, 5 + Gg PI 3-kinases PLCs Ca2+ PIP3
19
Overview: RNAi targeting of G proteins and regulators: Both gain of function and loss of function are observed
20
RNAi targeting G proteins and regulators: Both expected and unexpected results were obtained
21
RNAi targeting InsP and phosphoinositide metabolism: Both expected and unexpected results were obtained = “Expected” = “Unexpected”
22
RNAi targeting tyrosine kinases and scaffold proteins: Both expected and unexpected results were obtained = Expected = Unexpected
23
RNA-mediated RNAi: multiple phenotypes for C5a and IgG2a, but not for UDP
24
C5a, UDP and IgG2a stimulate distinct patterns of intracellular Ca2+ flux
IgG2a+ anti-IgG Ligand
25
RNA-mediated RNAi: multiple phenotypes for C5a and IgG2a, but not for UDP
26
Summary of shRNA-transduced RAW264.7 lines
37 Lines have been studied, covering 31 targets (4 new/week) Using prescreened shRNA plasmids, target knock-down was >75% in almost all transduced lines (protein or mRNA) >90% in two-thirds >99% in one-third Apart from receptor knock-downs, alterations in signaling were observed in: Half of responses to IgG2a One-third of responses to C5a Only one response to UDP by 1.5-fold cutoff, but more by stats Expected phenotypes were usually detected Unexpected phenotypes were frequent
27
Approaches to validation of RNAi phenotypes
Replicate lines with different shRNAs Alternate KD strategy (antisense, siRNA) Microarrays to look for off-target effects Knockdown reversal Test (and confirm) a likely hypothesis (e.g., with a 2nd knockdown)
28
Conclusions RNAi can be efficiently used in RAW264.7 cells
Results can be replicated Lines can be expanded Expected phenotypes are usually detected Unexpected and interesting phenotypes are frequent
29
Thanks Rick Brown, UCSF
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.